Sagility Q1 FY27 Revenue Up 27.6% YoY to ₹19,635 Cr, Adjusted PAT Grows 35.1%
Sagility Limited reported Q1 FY27 consolidated revenue of ₹19,635 million, up 27.6% YoY. Adjusted EBITDA grew 27.9% to ₹4,716 million, and Adjusted PAT increased 35.1% to ₹2,697 million. The company acquired CareSeed for USD 30.0 million to enhance healthcare quality capabilities. Sagility added 27 clients, reaching a total of 109.
The announcement includes robust financial performance with significant growth metrics and a strategic acquisition that expands the company's capabilities and client base. This is material information for investors.
The company reported strong year-on-year revenue growth, significant increases in Adjusted EBITDA and Adjusted PAT, and a substantial rise in Basic EPS. The acquisition of CareSeed is also a positive strategic move.
Sagility Limited announced its consolidated financial results for the first quarter of FY27 ended June 30, 2026. The company reported a revenue of ₹19,635 million (US$ 207.8 million), marking a year-on-year growth of 27.6% (15.2% in constant currency terms). The organic year-on-year growth was 27.3% (14.9% in constant currency). The reported revenue saw a sequential softening due to Q4 OE/AEP seasonality, but excluding this, steady-state organic revenue grew 5.1% quarter-on-quarter in constant currency terms, with seasonal revenues expected to return in Q3 and Q4 FY27.
Adjusted EBITDA stood at ₹4,716 million (US$ 49.9 million), representing 24.0% of revenue and a year-on-year growth of 27.9%. Adjusted Profit After Tax (PAT) grew by 35.1% year-on-year to ₹2,697 million (US$ 28.6 million), which is 13.7% of revenue. Basic Earnings Per Share (EPS) was ₹0.46, a 45.9% year-on-year increase, while Adjusted Basic EPS grew by 35.1% to ₹0.58.
In terms of business highlights, Sagility secured $35.3 million in steady-state Annual Contract Value (ACV), driven by expansions within existing clients and contributions from FY26 new client wins. The company added 27 clients in Q1 FY27, including CareSeed, bringing the total client base to 109. The acquisition of CareSeed, a U.S.-based healthcare technology company, is expected to strengthen Sagility's position in healthcare quality, particularly for Medicare Advantage plans, by adding differentiated analytics and HEDIS capabilities.
The company's Board of Directors also considered and approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, PricewaterhouseCoopers Services LLP was re-appointed as the Internal Auditors of the Company for the period from October 01, 2026, to March 31, 2028. The Board meeting commenced at 4:55 p.m. (IST) and concluded at 5:37 p.m. (IST) on July 21, 2026.
What to do with a filing like this
SAGILITY LIMITED filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SAGILITY LIMITED. Read the original for the full detail.